|
Haplotypes
|
DM (N =63)
|
PM (N = 18)
|
Myositis with ILD
|
Myositis with dysphagia
|
Control (N =100)
|
Controls vs. indicated patients ( p; OR [95% CI])
|
|---|
|
DRB1-DQA1-DQB1
|
n (%)
|
n (%)
|
n (%) N = 36
|
n (%), N = 9
|
n (%)
|
DM
|
PM
|
Myositis with ILD
|
Myositis with dysphagia
|
|---|
|
03-05-02
|
2 (1.59)
|
2 (5.56)
|
2 (2.78)
|
0 (0.00)
|
11 (5.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
04-03-03
|
6 (4.36)
|
1 (2.78)
|
5 (6.94)
|
1 (5.56)
|
9 (4.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
04-03-04
|
5 (3.97)
|
2 (5.56)
|
5 (6.94)
|
1 (5.56)
|
6 (3.00)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
07-01-02
|
12 (9.52)
|
1 (2.78)
|
8 (11.11)
|
2 (11.11)
|
7 (3.50)
|
0.031; 2.90
|
n/s
|
0.021; 3.45
|
n/s
|
|
(1.02–8.93)
|
(1.04–11.58)
|
|
07-03-02
|
6 (4.76)
|
0 (0.00)
|
3 (4.17)
|
2 (11.11)
|
11 (5.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
08-01-06
|
13 (10.32)
|
3 (8.33)
|
6 (8.33)
|
2 (11.11)
|
13 (6.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
09-03-03
|
17 (13.49)
|
2 (5.56)
|
3 (4.17)
|
3 (16.67)
|
20 (10.00)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
11-05-03
|
3 (2.38)
|
1 (2.78)
|
1 (1.39)
|
0 (0.00)
|
7 (3.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
12-01-03
|
11 (8.73)
|
2 (5.56)
|
8 (11.11)
|
0 (0.00)
|
11 (5.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
13-01-06
|
7 (5.56)
|
0 (0.00)
|
2 (2.78)
|
1 (5.56)
|
7 (3.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
14-01-05
|
2 (1.59)
|
1 (2.78)
|
0 (0.00)
|
2 (11.11)
|
7 (3.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
|
15-01-06
|
7 (5.56)
|
3 (8.33)
|
3 (4.17)
|
1 (5.56)
|
19 (9.50)
|
n/s
|
n/s
|
n/s
|
n/s
|
- n/s: not significant; n/a: not applicable; 1
p corr greater than 0.05; ILD: interstitial lung disease.